**Core Concept:** Uricosuric agents are medications that increase the excretion of uric acid in urine, helping to lower serum uric acid levels in patients with hyperuricemia, such as those with gout or certain types of kidney stones.

**Why the Correct Answer is Right:** Allopurinol is a prodrug that is converted to oxypurinol within the liver. Oxypurinol is a potent inhibitor of xanthine oxidase, which is responsible for the production of uric acid. As a result, allopurinol reduces serum uric acid levels by decreasing its synthesis. Allopurinol is not a uricosuric agent, making it the correct answer.

**Why Each Wrong Option is Incorrect:**

A. Allopurinol: As explained above, allopurinol is an inhibitor of xanthine oxidase, reducing uric acid production rather than promoting its excretion in urine.
B. Benzbromarone: This drug is a uricosuric agent, as it increases uric acid excretion without affecting its synthesis, making it incorrect.
C. Colchicine: Colchicine is primarily an anti-inflammatory agent used for gout management, not related to uric acid excretion. It is not a uricosuric agent, so it is incorrect.
D. Indomethacin: This drug is a nonsteroidal anti-inflammatory drug (NSAID) primarily used for pain relief and inflammation management, not related to uric acid excretion. Indomethacin is not a uricosuric agent, so it is incorrect.

**Clinical Pearl:** Uricosuric agents are essential for managing hyperuricemia and its complications such as gout. Indomethacin, colchicine, and benzbromarone are not uricosuric agents, while allopurinol is a xanthine oxidase inhibitor, not a uricosuric agent.

**Correct Answer:** Benzbromarone is a uricosuric agent, as it promotes the excretion of uric acid without affecting its synthesis, making it the correct answer.